CPHI Concludes Successfully | CongenPharma Connects Global Clients Through Innovative Peptide Technology
Publish Time:
2026-07-07
From June 16 to 18, 2026, the 24th CPHI & PMEC China—the World Pharmaceutical Ingredients Exhibition—concluded successfully at the Shanghai New International Expo Center. With an exhibition space of 240,000 square meters, the event brought together more than 3,600 premium suppliers from around the globe and attracted over 110,000 professional visitors from both domestic and international markets, further underscoring its status as Asia’s premier annual gathering for the pharmaceutical industry.
As a seasoned leader in the field of peptide synthesis, CongenPharma brings forth EMPHASES. ® Innovation Liquid-phase peptide synthesis The company showcased its cutting-edge technologies and a comprehensive GLP‑1 product portfolio at booth W9A25, marking a highlight moment for peptide technology throughout the three-day exhibition.
On-site Coverage
Huge popularity, lively negotiations.


During the exhibition, the Tongjun Pharmaceutical booth maintained steadily rising popularity. Pharmaceutical companies and API buyers from Europe and North America, Southeast Asia, South Asia, as well as China itself, CRO/ CDMO Institutions kept arriving in droves, with a steady stream of inquiries at the exhibition booth and every seat at the negotiation table fully occupied.

▲ The CongenPharma team at W9A25 Booth
Over the course of three days, the technical team engaged in in-depth discussions with hundreds of domestic and international clients. Semaglutide From the large-scale supply of intermediates and the custom synthesis of tirzepatide fragments, to… EMPHASES ® Platform’s technology licensing partnerships—each conversation revolves around a central premise: How to make high-quality peptides more affordable.
EMPHASES ® Innovative Liquid-Phase Peptide Synthesis Platform
World’s first green, high-efficiency, scalable technology reduces costs to one-third of those for solid-state solutions.
Our independently developed liquid-phase peptide synthesis technology platform has overcome the scalability limitations of traditional solid-phase synthesis. Leveraging this platform, CongenPharma has successfully achieved the efficient production of high‑impact peptides such as semaglutide and tirzepatide, offering customers end-to-end technical services that encompass process development, quality research, and scale‑up manufacturing.

▲ GLP-1 Sidechain Product Line Showcase
GLP-1 Side Chain Series
High-purity batches are stable, available in ton-scale quantities, and cost‑controlled.
· AEEA / AEEA-AEEA
· Fmoc-AEEA-OH / Fmoc-AEEA-AEEA-OH
· tBuO-C18-Glu(OtBu)-AEEA-AEEA-OH / tBuO-C20-Glu(OtBu)-AEEA-AEEA-OH
Short-peptide intermediate
Sequence‑Precise Isomer Control with Flexible Protecting Group Strategy
· Fmoc-His-Aib-OH / Fmoc-Ile-Aib-OH
· Fmoc-Tyr(tBu)-Aib-OH / Fmoc-Glu(OtBu)-Aib-OH
· Boc-L-His(Trt)-Aib-OH, etc.
Tirzepatide fragments
One-stop supply with quality traceability and custom synthesis support.
Coverage Tirzepatide synthesis The required peptide fragments and intermediates meet diverse needs, from kilogram‑scale R&D to ton‑scale scale‑up, helping clients advance their project pipelines efficiently.
SNAC oral permeation enhancer
Clinically validated key excipients for oral peptides
SNAC (Salcaprozate Sodium), a key excipient for oral semaglutide, is supplied by CongenPharma in high quality and in compliance with regulatory standards, supporting customers in advancing the development and commercialization of oral peptide formulations.

Pharmaceutical Peptides & Cosmetic Peptides
Third-party verification of the effectiveness of patent protection for independent brands
Pharmaceutical peptides — Semaglutide, Tirzepatide
Beauty peptides ——CG Oligo-1, Whitide ® Ⅰ Nine-peptide-1, CG GHK-Cu copper peptide, CG Arg acetyl hexapeptide-8, CG Pal-GHK palmitoyl tripeptide-1
Beauty-enhancing active ingredients
· Bisyne ® Bose–Einstein statistics
· CG HPR Ultra-Vision A / CG Retinol Retinol
· CG Chroman'6 ® Chromanol
· Dihydro-avenanthramide
Relevant Information
undefined

